Dotmatics, a leading provider of scientific informatics solutions and services, announced a new release of its informatics suite, Dotmatics 5.4; designed to handle very large data assays, with enhanced Browser search and featuring a newly refined Notebook interface.
Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received approval from the Medicines and Healthcare Product Regulatory Agency (MHRA) to begin production at itsClinical Services Centre of Excellence in Rhymney, Wales.
Catalent Pharma Solutions, a global leader in clinical supply services, announced the completion of its new, 30,000-square-foot clinical supply facility in Shanghai, China. The event was marked with an official opening ceremony at the site on April 10.
Thermo Fisher Scientific, the world leader in serving science, announced the availability of the Thermo Scientific CEDIA Mitragynine (Kratom) Assay, its newest drugs of abuse test that includes supporting calibrators and controls.
Sirio Pharma (SIRIO) – the nutraceutical contract development and manufacturing organization (CDMO) – announces global collaboration to help customers bring innovative, safe and effective products quickly to market.
Clinerion is partnering with Alpha MD to expand patient treatment options in India. Indian patients may be matched with international research studies by bringing Indian healthcare organizations onto the Patient Network Explorer platform.
Roivant Sciences and Sinovant Sciences announced the launch of Cytovant Sciences, a biopharmaceutical company focused on developing and commercializing innovative cellular therapeutics in Asia.
As a high-end conference and event week specially launched concurrently with CPhI China, organized by UBM EMEA, CCCMHPIE, and UBM Sinoexpo.
In full alignment with the cold storage needs of academic, pharmaceutical, biobanking and clinical laboratories, the new Standard Performance (STP) ultra-low temperature (ULT) freezer series offers a powerful solution: optimal sample protection, lower energy usage, significant operational savings and quieter operation.
Contained and sterile transfer solutions expert, ChargePoint Technology announces new, single use additions to its portfolio; the ChargePoint® Single Use Passive (SUP) and ChargeBag® PE-S with new HiPure ULP7 PE film.
Clinerion and Sigmasoft aim to bring access to international clinical studies for patients, physicians and healthcare institutions in Greece and Cyprus and to bring new treatments quicker to patients by accelerating trial recruitment.
Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds.
Romaco China will open a processing laboratory for solid pharmaceuticals on the Truking campus in Changsha right on time for the upcoming CIPM. Romaco will take advantage of the exhibition to show a selection of its packaging, tableting and processing technologies.
Aptar Pharma, the leader in respiratory drug delivery systems, is proud to announce its coorganization and diamond sponsorship of the Respiratory Drug Delivery (RDD®) Europe 2019 scientific conference, connecting pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal from May 7-10, 2019.
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – and Beta Pharma, a biotech company focusing on innovative drug discovery and development in oncology, announce a strategic partnership.
CRF Bracket announced a new release of TrialConsent®, the latest version of its revolutionary eConsent solution, with enhanced capabilities to support remote consenting in virtual clinical trials.
Some API enterprises have gradually shifted their R&D and production focuses to the high value-added characteristic APIs, and customized APIs and intermediates in recent years under the influence of the increasingly tightened environmental protection policy and decline of export prices due to excess capacity.
Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression.
Lonza has further strengthened its extensive mycoplasma detection portfolio with the addition of the Lucetta™ 2 Luminometer, a single-tube system designed to simplify and accelerate mycoplasma detection in cell cultures.
Almac Group announces Almac ONE™ – providing the first unified Clinical Trial Supply solution. This solution redefines the Clinical Supply Chain experience, creating a responsive end-to-end process that enhances visibility and accuracy throughout the lifecycle of a clinical study.
Data sharing specialist Nallian announces it will be launching the Global Pharma Tracker - Early Adopter Program at the IATA World Cargo Symposium in Singapore next week.
Szpital Specjalistyczny w Brzozowie, (the Specialist Hospital in Brzozów), Poland, specializes in oncology, hematology and cardiology.
TraceLink Inc., the world’s largest integrated digital supply network providing real-time information sharing for better patient outcomes, announced the submission of its interoperable blockchain network solution for the Food and Drug Administration (FDA) Pilot Project Program under the Drug Supply Chain Security Act (DSCSA).
Envigo, a leading provider of non-clinical contract research services and research models, announced the launch of PATHWAY – an integrated solution that optimizes non-clinical safety assessment programs to enable first-in-human clinical trials.
Pharmintech Exhibition turns the spotlight on technological innovation for the Life Science industry. From April 10 to 12, in Bologna.
The University of Debrecen, Clinical Center, has a strong reputation for clinical research, currently running over 360 trials, with 113 starting in 2018, alone.
Asia’s largest Biotechnology and Life-sciences forum and the annual flagship event of the Government of Telangana concluded after 3-days of insightful deliberations by global leaders of Life Sciences and healthcare.
Elsevier, the information analytics business specializing in science and health, announced that Lundbeck, the global pharmaceutical company specializing in brain diseases, has selected Elsevier’s Reaxys and Reaxys Medicinal Chemistry (RMC) to support the ambitions of its Research organization and accelerate data sharing and mining.
In recent years, big health has risen as a national policy of China with the introduction of the “Healthy China 2030” Planning Outline, and China has specified the new positioning of the nutrition and health food industry.
Animal Health & Feed Zone of CPhI China 2019 to Build a New Benchmark for the Industry
Over 1,500 delegates from more than 50 countries to attend Asia’s largest Biotechnology and Life-sciences forum. About 100 speakers from Government, Industry, Investors and Academia to participate in 3-day event in Hyderabad.
Linum Labs, a software development studio that builds blockchain-based solutions, has announced Molecule, a market platform to accelerate innovation in the pharmaceutical and biotech industry.
Merck known as MSD outside the United States and Canada, announced that the U.S. FDA has approved KEYTRUDA, Merck’s anti-PD-1 therapy.
Technology now plays a vital role in the healthcare sector. Anticipating industry innovations are critical to the prevention and treatment of specific ailments. Still, it's not enough to only learn about emerging technologies for the healthcare field.
Collaboration between two companies leads to more informed decisions for clinical researchers, grounded in real-world evidence.
Xellia Pharmaceuticals , a global leader in the manufacturing of specialty anti-infective treatments, announced t has received U.S. FDA approval for Premixed Vancomycin Injection in a Ready-to-Use (RTU) bag in the United States market.
West is pleased to announce that it has commenced discussions with Swissfillon AG, a provider of aseptic fill and finish services to pharmaceutical and biotechnology companies.
At POWTECH 2019 in Nuremberg, the plant manufacturing and process development specialist, Glatt, is presenting a groundbreaking waste-free process that recycles the phosphorus from ash to produce ready-to-use high-quality fertilisers.
Sharp has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution. Sharp’s IRT solution is used to manage patient interactions and drug supplies during clinical trials and perform a range of functions for sponsors, drug depots and investigative sites.
Takeda Pharmaceutical Co. announced that the EC extended the current marketing authorization of ADCETRIS to include treatment of adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma in combination with AVD (Adriamycin, vinblastine and dacarbazine).
Lonza announces the launch of DonorPlex Hepatocytes, a new line of high-quality cryopreserved pooled donor suspension hepatocytes, which are the first of their kind to be produced using Lonza’s novel patented manufacturing process.
MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases.
Silgan Dispensing, a global leader in the design, development and manufacturing of highly engineered pumps and sprayers in the pharmaceutical, home and beauty markets, will highlight its newest ophthalmic dispensing solution, Iridya™, at this year’s Pharmapack, Europe’s dedicated Pharmaceutical Packaging and Drug Delivery event.
Marken announced the expansion of its facilities in Philadelphia to include more space for logistics operations as well as a new GMP-compliant storage and distribution center to meet the growing demand for services in the area.
Daiichi Sankyo Company, Limited announced that the U.S. FDA has accepted a New Drug Application (NDA) and granted Priority Review for pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT).
Dotmatics and TetraScience announced that they have formed a strategic partnership. The partnership is designed to bring R&D labs an improved relationship with their scientific data. Dotmatics is a leading provider of scientific informatics solutions and services; TetraScience is an R&D data integration platform.
Clariant, a world leader in specialty chemicals, is introducing new polymer compounds specially formulated to limit or even eliminate hydrolytic degradation, which is known to affect certain materials commonly used in catheters.
The FUSE conference will be held April 8-10, 2019 at the Radisson Blu Aqua in Chicago, IL. FUSE is the marquis platform for creating powerful dialogue between business and creative leaders around brand and design’s intent, investment, and impact.
Contract development and manufacturing organization (CDMO), Particle Sciences, a Lubrizol LifeSciences company, has announced its partnership with leading Indian contract manufacturing organization (CMO), Encube Ethicals.
Neovasc Inc. ,a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina.
Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, announces that it has entered into an exclusive strategic partnership with Rutgers, The State University of New Jersey , to develop and commercialise a novel gene editing technology, known as base editing.
Zenith Technologies, a world leader in delivering manufacturing software solutions to the life sciences industry, has seen a 150% rise in demand for its consultancy arm services.
Powder containment and sterile transfer solutions provider, ChargePoint Technology has achieved HazLoc (Hazardous Area) certification for VERIFI to further support customers in North America.
CRISPR Therapeutics , a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and ProBioGen.
The US FDA has granted approval for Samsung Bioepis to use Ontruzant (trastuzumab-dttb) to treat a range of cancers.
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced the launch of the BIOSTAT® RM TX single-use bioreactor, a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies.
Quanticate, a leading global data-focused clinical research organisation (CRO) has launched QVigilance to provide dedicated pharmacovigilance (PV) and risk management services.
Eisai Co., Ltd. and Purdue Pharma L.P. announced that a new drug application has been submitted to the U.S. FDA for lemborexant, an investigational agent for sleep-wake regulation, seeking approval for the treatment of insomnia, a sleep-wake disorder.
As the pharmaceutical industry has changed and grown in the last two decades, there are increasing concerns about the safe handling of active pharmaceutical ingredients (APIs)– particularly in the process of removing catalysts from API slurries which has a direct impact on the quality of pharmaceutical products.
As China continues to advance from a big country in pharmaceuticals to a power in pharmaceuticals, and the global economy maintains good trends, the main business income of API manufacturing in China has reached RMB499.1 billion, growing by 14.68% year on year; and the export of APIs has reached USD29.1 billion, growing by 13.7% year on year.
The bio-pharma industry has entered the new stage of rapid development in recent years with the continuous development of the cutting-edge biological technology and the emerging and marketing of new targeted drugs and cell therapies, etc.
Lonza will unveil PyroTec™ PRO, the first-ever fully automated, plate-based robotic solution for endotoxin detection at SLAS2019 International Conference and Exhibition (2-6 February, Washington, DC, USA).
MedPharm Ltd has announced the expansion of its US Center of Excellence in Durham, North Carolina in response to increasing service demand for its topical and transdermal formulation development and performance testing services.
Hong Kong International Airport (HKIA) and Brussels Airport announced the launch of an airport-to-airport (A2A) pharma corridor, offering services catering to the specific needs of pharmaceutical shipments.
Omya, a leading manufacturer of mineral ingredients, has developed two new tablet concepts which were introduced at Health ingredients Europe 2018.
PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, introduced a new, dedicated division to support emerging biotech companies in reaching their drug development and commercialization goals quickly and cost-effectively.
Medigene AG reported that an additional European Patent was granted for its dendritic cell (DC) vaccine platform.
Aptar Pharma is pleased to announce the co-organization and diamond sponsorship of the Respiratory Drug Delivery (RDD®) Europe 2019 scientific conference, which will connect pulmonary and nasal drug delivery experts from around the world in Estoril, Portugal, May 7-10, 2019.
The US FDA has approved Portola Pharmaceuticals’ Prior Approval Supplement (PAS) for the manufacturing process of second generation Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo].
Eisai Co., Ltd. announced that its in-house discovered and developed antiepileptic drug (AED) perampanel , for which a NDA was submitted for review as an adjunctive treatment for partial onset seizures in epilepsy patients 12 years of age and older in China in October 2018, has been designated for Priority Review by the NMPA due to perampanel's significant clinical benefit compared to existing treatments.
North Estonia Medical Centre (NEMC) consists of seven clinics and 32 specialist centers, and is the most important caregiver in the capital of Estonia, Tallinn, as well as in the northern part of the country.
Monoclonal antibodies (MAbs) have been extraordinary tools in the field of bioscience due to their high level of specificity and selective binding ability.
Swedish life science company, OnDosis, and global contract development and manufacturing organisation (CDMO), Recipharm, have entered into an agreement for the formulation development of an ADHD treatment for the US market.
Axol Bioscience, the human cell culture specialist, is launching a new line of Human induced Pluripotent Stem Cells (iPSC)-derived Microglia for the consistent and reproducible study of neuroglia and their involvement in neurodegenerative diseases, including Alzheimer’s disease, multiple sclerosis and Parkinson’s disease.
Genoscience Pharma, a clinical-stage biotechnology company dedicated to discovering and developing anticancer drugs, is delighted to announce that it received the Most Innovative European Biotech SME Award for 2018 in the Healthcare category at EuropaBio.
Labviva, an AI-powered digital marketplace for life science reagents, instrumentation and services announces its launch to create scientifically informed purchasing decisions.
AstraZeneca announced a new collaboration with Cancer Research UK to launch a centre of excellence in genetic screening, cancer modelling and big data processing aimed at accelerating the discovery of new cancer medicines.
Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global Initiative for Chronic Obstructive Lung disease) Scientific Committee as one of the commonly used maintenance medications in COPD (Chronic Obstructive Pulmonary Disease).
The Santa Casa da Misericordia hospital of Porto Alegre, Brazil, will expand Clinerion’s network of partner hospitals in Brazil. Patients from the hospital’s seven clinics will gain access to leading-edge, innovative medical treatment via Clinerion’s Patient Network Explorer platform.
UBM India, India's leading B2B exhibition organizer, is all set to bring in the third edition of the widely appreciated India Pharma Week, a week-long celebration packed with avant-garde events from 9th – 14th December, alongside the 12th edition of its flagship expo CPhI and P-MEC India.
The new VACUETTE® branded SAFELINK tube holder facilitates quick and easy blood collection. The tube can be used in combination with all medical products that have a standard female luer lock connection, such as winged cannulae. Above all, it stands out thanks to its simple handling.
DuPont Nutrition & Health (DuPont) will offer ingredients to enable the design of patient-centric, speed-to-market solutions to advance consumer health at CPhI India, Dec. 12-14 in Delhi, India.
The EORTC Brain Tumor Group and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunotherapy Array to identify autoantibody biomarkers that investigate the immunological profile and immuno-competence of long-term Glioblastoma survivors.
Cios Fit-a multidisciplinary mobile C-arm ready for demanding environments, was introduced at the 63rd Annual Indian Orthopaedic Association Conference, Coimbatore, on November 28th, 2018; setting a benchmark in mobile C-arms.
It was inaugurated by Dr.S Rajasekaran, Chairperson of AOSpine (International community of Spine Surgeons, headquartered in Switzerland).
Cios Fit is designed to help in improving quality of care, achieve efficient workflows, and profit from high uptime; thereby reducing avoidable costs. It is built for the tough job in the Operation Room (OR) where the equipment needs to deliver high quality imaging, be simplified in its usage and robust to last for long; while ensuring price point is not exceeded.
With Cios Fit-powerful imaging technology, the surgeons are able to maintain consistency with crystal clear images of anatomical structures, implants, screws and devices resulting in accurate treatment and thus improving patient experience.
Dr. Nanjappa K.M. of Cauvery Uroderm Center, at Kalyan, near Mumbai, where Cios Fit was recently tested shared his experience while performing an Endo-urology procedure. He mentioned, “Cios Fit has an exceptional image quality, which is the best I have experienced so far. The touch screen display and the printer with the machine is a good add on feature for documentation.
Moreover, the pulse mode of the machine is so well integrated with the software, that the dynamic images in this mode are very smooth, without any ghosting and lags. The best part of the machine is its radiation dose per case, significantly lower than any of the other machines available today. Overall, it’s a good, compact, sleek, feature-rich asset”. In an OR set up where surgeries need to be performed with minimum assistance, the Cios Fit can be easily used and maneuvered with its light weight design by a single assistant.
It has a built-to-last design, which aims to enable consistent performance and high uptime, no matter how intensely it is used. In order to improve the machine’s durability, sensitive elements are replaced with a shock resistant SD card that helps to handle the intense OR environment; thereby cutting down on avoidable costs. Smart radiation dose management with dedicated pediatric mode and smart power management for patients with diverse needs, ensure safety in the OR not only for patients but also for the surgeon and other OR staff. Imaging gets simplified with the unique touch and play concept of Cios Fit, where the image and dose both can be optimized with just one button push.
Free movements with 380° C-arm angulation with no need to lock it after each movement, simplifies the entire process for the OR team. Moreover, its small footprint and light weight design eases the Door-to-Door transfer for the OR staff. Fast boot time, dynamic and high quality imaging, ease of documentation of the procedure with a USB port and an instant connection to the printer and easy maneuverability are the key features of Cios Fit.
Sanjay David, Business Area Head – Advanced Therapies, Siemens Healthineers, India said, “The Cios Fit mobile C-arm is designed for the tough environment in an OR, where there are multiple procedures in a day to be performed; keeping in mind the high patient load at the medical institutions. Cios Fit addresses many concerns of all the stakeholders, right from healthcare professionals to operators and patients, as part of our endeavor in transforming care delivery”.
About Siemens Healthineers
Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving patient experience and digitalizing healthcare. A leader in medical technology, Siemens Healthineers is constantly innovating its portfolio of products and services in its core areas of diagnostic and therapeutic imaging and in laboratory diagnostics and molecular medicine. Siemens Healthineers is also actively developing its digital health services and enterprise services. In fiscal 2018, which ended on September 30, 2018, Siemens Healthineers generated revenue of €13.4 billion and adjusted profit of €2.3 billion and has about 50,000 employees worldwide. Further information is available at www.siemens.co.in/healthineers
IQV announced that Napo Pharmaceuticals, Inc. , a wholly-owned subsidiary of Jaguar Health, Inc., has selected Orchestrated Customer Engagement , IQVIA Technologies’ innovative commercial solutions suite, to support Napo’s growing commercial organization and enable it to work more closely with healthcare providers.
Yposkesi, a leading CDMO for gene therapy viral vector manufacturing, today announces an agreement in principle governing the terms of a strategic partnership with Axovant Sciences, a company developing innovative gene therapies for neurologic and neuromuscular diseases.
Zenith Technologies, a world leader in delivering GMP manufacturing software solutions to the life sciences industry, recently conducted an industry survey that suggests the digitalisation of manufacturing is a top priority.
IQVIA announced that Adhera Therapeutics Inc. has selected Orchestrated Customer Engagement (OCE), IQVIA Technologies’ transformational commercial platform, to build its commercial infrastructure and bring the company’s specialty drug innovations to patients.
Clinerion has added a live heatmap to its homepage indicating prevalence of searchable disease indications by ICD10 code according to the global patient network in its Patient Network Explorer.
Sygnature Discovery a leading independent integrated drug discovery and pre-clinical services company, is continuing the expansion of its operations with the opening of its first US office, located in Harvard Square, Cambridge, Massachusetts.
The Bridging Clinical Research & Clinical Health Care Collaborative, a forum where health care professionals, patients, physicians, academics, clinical researchers, service and technology providers, and regulatory authorities convene to advance clinical research and its integration with health care, has released a preliminary list of its 2019 agenda topics.
Analytical scientists and laboratory managers seeking high-performing, multi-functional instruments with low cost of ownership can now benefit from a new FTIR spectrometer designed to analyze complex samples quickly and deliver fast, accurate results.
Analytical scientists and laboratory managers seeking high-performing, multi-functional instruments with low cost of ownership can now benefit from a new FTIR spectrometer designed to analyze complex samples quickly and deliver fast, accurate results.
PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy , and RxCrossroads by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative program to simplify the channel for precision medicine therapies.
Regeneron Pharmaceuticals, Inc. and Sanofi announced that new analyses on mortality from the 18,924-patient ODYSSEY OUTCOMES trial were presented at the American Heart Association (AHA) Scientific Sessions 2018.
Quanticate, a data-focused clinical research organisation (CRO), has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD project.